Regeneron antibody ‘cocktail’ wins emergency-use authorization from FDA
Published
Published
By C. Todd Lopez
On Saturday, the Food and Drug Administration issued an emergency use authorization, or EUA, for..
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people..